ventana.jpgCan anyone tell me anything about Ventana Biotech? It seems that nobody knows anything about this company.

A  biotechnology company that develops anti-obesity solutions, Ventana Biotech, Inc. (VNTA.PK) has recently appointed Vijay Guptha to its Advisory Board. The President of the company seems to be excited to have Mr. Guptha in his company: “We are delighted to have Dr. Guptha join our Advisory Board. He is an esteemed scholar, experienced pharmaceutical research professional and a respected advisor to numerous companies around the globe.”

At least, I hope that something is going to change in the company and the stock will move out of the limit of $0.68. In addition, stock promotional campaign should also give a hand. According to the latest news, OTC Stock Exchange was just paid $40,000, while different companies, including Stock Egg, Stock Rich, HotOTC, and Cool Penny Stocks, got $60,000 in total some time ago.

The only thing we can do about this company is just to sit and wait for what is going to happen next. Maybe you have a clue about that?